Hengrui presents 64 oncology studies at ESMO 2026
Hengrui Pharma presented 64 oncology studies at the ESMO Congress 2026.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
Hengrui Presents 64 Oncology Research Studies at ESMO Congress
Hengrui said it presented 64 research studies at the 2026 ESMO Congress, highlighting its oncology research and development work.